Terms: = Gastric cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
161 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. The inflammation score predicts the prognosis of gastric cancer patients undergoing Da Vinci robot surgery.
Chen X; Zhang Y; Liu Z; Song J; Li J
J Robot Surg; 2024 Mar; 18(1):131. PubMed ID: 38498240
[TBL] [Abstract] [Full Text] [Related]
3. Analysis and Prediction of Significant Genes in gastric cancer Based on TCGA Database.
Li R; Lu Y; Yi Z; An J
Stud Health Technol Inform; 2023 Nov; 308():445-454. PubMed ID: 38007771
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of Clinicopathological Features and prognosis of Mucinous gastric Carcinoma and other gastric cancers: A Retrospective Study of 4,417 Patients.
Ma Y; Zhang S; Wang Y; Hu C; Chen J; Pang C; Liang C; Yuan L; Du Y
J Gastrointest Surg; 2023 Nov; 27(11):2352-2364. PubMed ID: 37848685
[TBL] [Abstract] [Full Text] [Related]
6. A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.
Huang B; Ding F; Li Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15845-15854. PubMed ID: 37672074
[TBL] [Abstract] [Full Text] [Related]
7. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection.
Xie Q; Zhao Z; Yang Y; Long D; Luo C
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14983-14996. PubMed ID: 37606762
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract] [Full Text] [Related]
9. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of influencing factors of nerve invasion in locally advanced gastric cancer.
Ren XC; Liang P
Abdom Radiol (NY); 2023 Sep; 48(9):3005-3011. PubMed ID: 37289214
[TBL] [Abstract] [Full Text] [Related]
11. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
[TBL] [Abstract] [Full Text] [Related]
12. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract] [Full Text] [Related]
13. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS).
Yang X; Wang A; Li J; Zhou K; Ji K; Ji X; Zhang J; Wu X; Bu Z
BMC Cancer; 2023 Jan; 23(1):53. PubMed ID: 36647059
[TBL] [Abstract] [Full Text] [Related]
15. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract] [Full Text] [Related]
16. A new biomarker for the early diagnosis of gastric cancer: gastric juice- and serum-derived SNCG.
Pan Y; Zheng Y; Yang J; Wei Y; Wu H; Liu S; Yin A; Hu J; Zeng Y
Future Oncol; 2022 Sep; 18(28):3179-3190. PubMed ID: 35947016
[TBL] [Abstract] [Full Text] [Related]
17. Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis.
Zhang Z; Miao L; Wang S; Zhao Y; Xie Y; Yun H; Ren Z; Wang G; Teng M; Li Y
World J Surg Oncol; 2022 Jun; 20(1):204. PubMed ID: 35710379
[TBL] [Abstract] [Full Text] [Related]
18. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
Sun Y; Chang W; Yao J; Liu H; Zhang X; Wang W; Zhao K
J Int Med Res; 2022 Apr; 50(4):3000605221091095. PubMed ID: 35469480
[TBL] [Abstract] [Full Text] [Related]
19. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients.
Chen Y; Zhang J; Liu J; Wang J; Shi C; Lu L; Cheng X; Niu G; Zhang S
J Immunol Res; 2022; 2022():1817694. PubMed ID: 35224110
[TBL] [Abstract] [Full Text] [Related]
20. C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.
Zhang Y; Lu L; He Z; Xu Z; Xiang Z; Nie RC; Lin W; Chen W; Zhou J; Yin Y; Xie J; Zhang Y; Zheng X; Zhu T; Cai X; Li P; Chao X; Cai MY
Front Immunol; 2022; 13():808101. PubMed ID: 35185894
[TBL] [Abstract] [Full Text] [Related]
[Next]
